William Vainchenker

26PUBLICATIONS
112CO-AUTHORS
Haematological tumoursMolecular targetsCardiovascular medicine and haematology not elsewhere classifiedMedical mycologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 25, 2026
Characterization of disease-initiating hematopoietic stem cells in calreticulin-mutated myeloproliferative neoplasms.

|Jan 09, 2026
Next-generation JAK inhibitors in the treatment of myeloproliferative neoplasms.

Stefan N Constantinescu, William Vainchenker, Christian Pecquet

|Jul 07, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.

Nabih Maslah, Nina Kaci, Blandine Roux

|Sep 10, 2024
Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPN.

Edimara S Reis, Rebecca Buonpane, Hamza Celik

|Dec 26, 2023
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.

Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur

|Sep 04, 2023
Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution.

Alba Rodriguez-Meira, Ruggiero Norfo, Sean Wen

Pageof 5

Frequent Collaborators

11 joint publications

Isabelle Plo

9 joint publications

Hana Raslova

6 joint publications

Caroline Marty

5 joint publications

Stefan N Constantinescu